| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/22/1987 | CA1227194A1 Antibacterial penem derivatives |
| 09/22/1987 | CA1227140A1 Oral compositions |
| 09/22/1987 | CA1227139A1 Oral product for controlling gingivitis |
| 09/22/1987 | CA1227136A2 Pharmaceutical compositions containing 4-(benzofuran- 2-yl)4-oxo buten-2-oic acid and/or one of the pharmaceutically acceptable salts thereof as an active ingredient |
| 09/22/1987 | CA1227135A1 Nephrotoxicity inhibitors for aminoglycoside antibiotics |
| 09/17/1987 | DE3641491A1 Pharmaceutical compositions with antitumour action |
| 09/17/1987 | DE3608684A1 Therapeutic product containing hydrogenated ergot alkaloids and a low molecular weight heparin stabilised against loss of activity |
| 09/17/1987 | DE3608006A1 Use of anhydrous alcoholic solutions of diphenyl and/or diphenyl derivatives as medicine for internal use |
| 09/16/1987 | EP0237516A1 Benzyl-pyrimidine derivatives, process for their preparation and compositions containing them |
| 09/16/1987 | EP0237482A1 Derivatives of C(29)-carbonyloxy-milbemycine against parasites in animals and plants |
| 09/16/1987 | EP0237472A2 An ameliorating agent for pulmonary fibrosis and the use thereof |
| 09/16/1987 | EP0237467A2 Heteroaryl-oxy-beta-carboline derivatives, their preparation and use as medicaments |
| 09/16/1987 | EP0237450A2 Platinum (IV) complexes |
| 09/16/1987 | EP0237411A1 (Piperidino-3)propoxy-5p-cymene, its acetyl, acetoxy and hydroxy derivatives, salts of these products, process for the preparation of these compounds and medicines containing at least one of these products as active principle |
| 09/16/1987 | EP0237397A1 Steroids saturated in 9(11) and substituted in position 10 by a radical containing a triple bond, process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 09/16/1987 | EP0237366A1 Amino alcohols, process for their preparation and their applications, in particular for therepeutical use |
| 09/16/1987 | EP0237348A1 Cell protection |
| 09/16/1987 | EP0237347A2 1,2,3,4-Tetrahydro-6-substituted-4-aryl (or heterocyclo)-3-[(substituted amino)carbonyl]-2-thioxo (or oxo)-5-pyrimidinecarboxylic acids and esters |
| 09/16/1987 | EP0237341A1 Macrolide compounds |
| 09/16/1987 | EP0237281A1 2-alkoxy-N-(1-azabicyclo[2.2.2]-oct-3-yl) benzamide-N-oxides in the control of emesis caused by anticancer drugs |
| 09/16/1987 | EP0237264A2 Process for preparing phosphonyloxyacyl amino acids and derivates thereof |
| 09/16/1987 | EP0237248A2 2-[(2-Pyridyl)methylsulfinyl]thienoimidazoles and related compounds as antiulcer agents |
| 09/16/1987 | EP0237200A2 Use of basic inorganic salts of magnesium or calcium for the stabilisation of benzimidazole derivatives |
| 09/16/1987 | EP0237191A1 3-alkoxy-2-aminopropylamines useful as cardiovascular agents |
| 09/16/1987 | EP0237169A1 5-Substituted octahydroindolizine analgesics compounds and 7-keto intermediates |
| 09/16/1987 | EP0237166A2 Cytotoxic substances from the marine cyanophyte hormothamnion enteromorphoides grunow |
| 09/16/1987 | EP0237159A2 2 Stage drug delivery device |
| 09/16/1987 | EP0237125A1 Novel tricyclic amino compounds |
| 09/16/1987 | EP0237084A2 4-Bromomethyl-5-methyl-1,3-dioxolen-2-one, and a process for the production thereof |
| 09/16/1987 | EP0237082A2 3,5-disubstituted 4,5-dihydroisoxazoles as transglutaminase inhibitors |
| 09/16/1987 | EP0237028A1 N-(phenyl) or n-(phenylcyclopropyl)-2,5-dihydro-2-oxo-4, (substituted phenyl) amino-3-furancarboxamide derivatives |
| 09/16/1987 | EP0236951A2 Use of diphenyl hydantoin and its derivatives in the preparation of a pharmaceutical agent for the treatment of immune diseases |
| 09/16/1987 | EP0236942A2 2'-Deamino-2'-hydroxyistamycin Bo derivatives of low toxicity |
| 09/16/1987 | EP0236940A2 Alpha-heterocycle substituted tolunitriles |
| 09/16/1987 | EP0236939A1 Derivatives of 5-acyloxy-13-beta-alkyl milbemicyne against parasites in animals and plants |
| 09/16/1987 | EP0236931A2 Aromatic omega-alkylimino-tetrahydro-6H-1,3-Thiazin-6-one derivatives |
| 09/16/1987 | EP0236930A1 Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives |
| 09/16/1987 | EP0236913A2 Aryl-azolylmethyl-benzocyclo-alkene derivatives, process for their preparation and their use |
| 09/16/1987 | EP0236894A2 Efomycine G, its preparation and its use as an animal growth promotor |
| 09/16/1987 | EP0236880A2 Penem derivatives |
| 09/16/1987 | EP0236872A2 Hydroxyl amine derivatives, their preparation and use as medicaments |
| 09/16/1987 | EP0236855A1 Pharmaceutical composition |
| 09/16/1987 | EP0236838A2 Aminoester-dihydropyridines, process for their preparation and their use |
| 09/16/1987 | EP0236822A2 Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis((2-(hydroxyethylamino)-ethyl)amino)anthraquinone, dihydrochloride |
| 09/16/1987 | EP0236684A2 Galanthamine or analogues thereof for treating Alzheimer's disease |
| 09/16/1987 | EP0236679A1 Nicorandil-containing preparation for injection |
| 09/16/1987 | EP0236673A2 Process for quinoline-3-carboxylic acid antibacterial agents |
| 09/16/1987 | EP0236667A2 Quinone derivatives as antitumour agents |
| 09/16/1987 | EP0236646A1 Ortho-anisamides, process for their preparation and their pharmaceutical applications |
| 09/16/1987 | EP0236636A2 Use of clonidine derivatives for the preparation of ocular hemostatic agents |
| 09/16/1987 | EP0236628A1 Inhibition of the 5-lipoxygenase pathway |
| 09/16/1987 | EP0236624A2 Substituted phenyl ethanol amines, processes for their preparation and pharmaceutical compositions containing them |
| 09/16/1987 | EP0236572A1 Method for healing bone damage and composition |
| 09/16/1987 | EP0236510A1 Prostacyclins and drugs containing the same |
| 09/16/1987 | EP0236487A1 Virus inactivation |
| 09/16/1987 | EP0236476A1 Oxygenated perfluorinated perfusion of the ocular globe. |
| 09/16/1987 | EP0236390A1 Agent against multiple sclerosis. |
| 09/16/1987 | EP0236383A1 Method for preparing 6beta-halopenicillanic acids and salts thereof. |
| 09/16/1987 | EP0236329A1 Amino-salicylic acid derivatives and pharmaceutical compositions |
| 09/16/1987 | CN87101731A 8-position substituted quinolonecarboxylic acid derivatives and process fortheir preparation |
| 09/16/1987 | CN87101647A 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates |
| 09/16/1987 | CN87100978A Dihydrobenzofuran-and chromancarboxamide derivatives, processes for the preparation thereof and use thereof as neuroleptics |
| 09/16/1987 | CN87100799A Antibacterial drugs for fish |
| 09/16/1987 | CN87100723A Quinone derivatives, their production and use |
| 09/16/1987 | CN87100159A Use of membrane modulators and products comprising such membrane modulators |
| 09/16/1987 | CN87100040A Diaryl alkyl-substituted alkylamine and process for manufacture, use the medicine containing this chemical compound |
| 09/16/1987 | CN86105436A Modulation of aids virus-related events by double-stuanded rnas |
| 09/15/1987 | US4694080 2H-1,2-benzothiazine derivatives |
| 09/15/1987 | US4694079 Crystalline dimethylformamide solvate |
| 09/15/1987 | US4694076 Chemical intermediate, enzyme inhibitor, or purification of enzyme or antigen |
| 09/15/1987 | US4694024 Anticoagulant mixture |
| 09/15/1987 | US4694023 Alpha-alkyl polyolefinic carboxylic acids and derivatives thereof useful in the treatment of psoriasis and allergic responses |
| 09/15/1987 | US4694021 Method for topical treatment of scar tissue |
| 09/15/1987 | US4694015 Pharmaceutical or veterinary compositions containing thiosulfonate derivatives |
| 09/15/1987 | US4694011 Novel 7-hydroxy-indoles |
| 09/15/1987 | US4694010 Diphenylhydantoin as potentiator for dextromethorphan as antiepileptic |
| 09/15/1987 | US4694008 Chemical compounds |
| 09/15/1987 | US4694007 Acquired immune deficiency syndrome |
| 09/15/1987 | US4694006 Acyl- or acyloxymethyl-allopurinol prodrugs |
| 09/15/1987 | US4694005 5-phenyl-3H,6H-1,3,4-oxadiazine-2-ones in treatment of heart failure and hypertension |
| 09/15/1987 | US4694002 Hypotensive agents |
| 09/15/1987 | US4694001 β-lactam compound and a pharmaceutical composition containing the same |
| 09/15/1987 | US4693999 Antiinflammatory, antiallergen agents |
| 09/15/1987 | US4693996 Method of treating heart failure and medicaments therefor |
| 09/15/1987 | US4693995 Pharmaceutical composition for the treatment of acute myocardial ischemia |
| 09/15/1987 | US4693896 Ethylcellulose-coated, gastric-disintegrable aspirin tablet |
| 09/15/1987 | US4693885 Tetrapyrrole therapeutic agents |
| 09/15/1987 | US4692459 Anti-hypertensive agents |
| 09/15/1987 | EP0165970A4 Hair growth modification. |
| 09/15/1987 | CA1226866A1 Hydantoin derivatives |
| 09/15/1987 | CA1226818A1 Oral galenicals of sulpiride |
| 09/15/1987 | CA1226817A1 PHARMACEUTICAL COMPOSITION COMPRISING, ON THE ONE PART, AS ACTIVE PRINCIPLE THE 9.alpha.,11.beta.-DICHLORO 16.alpha.-METHYL 21-OXYCARBONYLDICYCLOHEXYL METHYLOXY PREGNA-1, 4 DIENE 3,20 DIONE ANDON THE OTHER, A POORLY REACTIVE PHARMACEUTICAL EXCIPIENT PERMITTING |
| 09/15/1987 | CA1226816A1 Inhibition of angiogenesis |
| 09/11/1987 | WO1987005297A1 Cephalosporin derivatives |
| 09/11/1987 | WO1987005296A1 2-[(2-pyridyl)methylsulfinyl]thienoimidazoles and related compounds as antiulcer agents |
| 09/11/1987 | WO1987005294A1 Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs |
| 09/11/1987 | WO1987005221A1 Methods and materials for treatment of rheumatoid arthritis |
| 09/11/1987 | WO1987005217A1 Process for the preparation of a viscosity-stable antacid composition |
| 09/11/1987 | WO1987005216A1 COMBINATION OF AROMATASE INHIBITORS AND 5alpha-REDUCTASE INHIBITORS |
| 09/11/1987 | WO1987005215A1 Anti-allergic agent |